1. Fisher CG, Goldschlager T, Boriani S, et al. A novel scientific model for rare and often neglected neoplastic conditions. Evid Based Spine Care J 2013;4:160–2.
2. Varga PP, Szoverfi Z, Lazary A. Surgical treatment of primary malignant tumors of the sacrum. Neurol Res 2014;36:577–87.
3. Dea N, Fisher CG, Reynolds JJ, et al. Current treatment strategy for newly diagnosed chordoma of the mobile spine and sacrum: results of an international survey. J Neurosurg Spine 2018;30:119–25.
4. Bible JE, Mirza M, Knaub MA. Blood-loss management in spine surgery. J Am Acad Orthop Surg 2018;26:35–44.
5. Varga PP, Szoverfi Z, Fisher CG, et al. Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival. Eur Spine J 2015;24:1092–101.
7. Dolan RT, Butler JS, Wilson-MacDonald J, et al. Quality of life and surgical outcomes after soft-tissue reconstruction of complex oncologic defects of the spine and sacrum. J Bone Joint Surg Am 2016;98:117–26.
8. Ruggieri P, Angelini A, Pala E, Mercuri M. Infections in surgery of primary tumors of the sacrum. Spine (Phila Pa 1976) 2012;37:420–8.
9. Angelini A, Pala E, Calabro T, Maraldi M, Ruggieri P. Prognostic factors in surgical resection of sacral chordoma. J Surg Oncol 2015;112:344–51.
10. Arikan M, Togral G, Hasturk AE, Aktas E, Gungor S. Management and retrospective analysis of primary and metastatic sacral tumors and infections: evaluation with 73 cases. Eklem Hastalik Cerrahisi 2014;25:126–32.
11. Gao S, Zheng Y, Liu X, Tian Z, Zhao Y. Effect of early fasting and total parenteral nutrition support on the healing of incision and nutritional status in patients after sacrectomy. Orthop Traumatol Surg Res 2018;104:539–44.
12. Guo Y, Palmer JL, Shen L, et al. Bowel and bladder continence, wound healing, and functional outcomes in patients who underwent sacrectomy. J Neurosurg Spine 2005;3:106–10.
13. Feghali J, Pennington Z, Hung B, et al. Sacrectomy for sacral tumors: perioperative outcomes in a large-volume comprehensive cancer center. Spine J 2021;21:1908–19.
14. Fourney DR, Rhines LD, Hentschel SJ, et al. En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine 2005;3:111–22.
16. Zang J, Guo W, Yang Y, Wei R. Surgical treatment of giant benign sacral neurogenic tumors using the posterior-only approach. Clin Neurol Neurosurg 2019;185:105483.
17. Sciubba DM, Nelson C, Gok B, et al. Evaluation of factors associated with postoperative infection following sacral tumor resection. J Neurosurg Spine 2008;9:593–9.
18. Moran D, Zadnik PL, Taylor T, et al. Maintenance of bowel, bladder, and motor functions after sacrectomy. Spine J 2015;15:222–9.
21. Chen KW, Yang HL, Lu J, et al. Risk factors for postoperative wound infections of sacral chordoma after surgical excision. J Spinal Disord Tech 2011;24:230–4.
22. Marmouset D, Haseny B, Dukan R, et al. Characteristics, survivals and risk factors of surgical site infections after en bloc sacrectomy for primary malignant sacral tumors at a single center. Orthop Traumatol Surg Res 2022;108:103197.
23. Klemencsics I, Lazary A, Szoverfi Z, Bozsodi A, Eltes P, Varga PP. Risk factors for surgical site infection in elective routine degenerative lumbar surgeries. Spine J 2016;16:1377–83.
24. Fang A, Hu SS, Endres N, Bradford DS. Risk factors for infection after spinal surgery. Spine (Phila Pa 1976) 2005;30:1460–5.
25. Mezrow CK, Bergstein I, Tartter PI. Postoperative infections following autologous and homologous blood transfusions. Transfusion 1992;32:27–30.
26. De la Garza Ramos R, Gelfand Y, Benton JA, et al. Rates, risk factors, and complications of red blood cell transfusion in metastatic spinal tumor surgery: an analysis of a prospective multicenter surgical database. World Neurosurg 2020;139:e308–15.
27. Nakai S, Yoshizawa H, Kobayashi S, Naga K, Ichinose H. Role of autologous blood transfusion in sacral tumor resection: patient selection and recovery after surgery and blood donation. J Orthop Sci 2000;5:321–7.